ArticleBone reports2026
Fracture prediction using 3D-DXA-finite element based femoral strength: a prospective study in postmenopausal women.
Article in Bone reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although areal bone mineral density (aBMD) measured by DXA is a good predictor of fractures, nearly half of low-trauma fractures occur in individuals without osteoporosis (T-score > -2.5 SD). This study investigated whether femoral strength estimated from 3D DXA-based finite element (FE) analysis enhances the prediction of incident fractures compared with conventional 2D DXA-derived aBMD. Baseline hip DXA scans from 740 postmenopausal women in the Geneva Retirees Cohort were analyzed. 3D reconstructions of the proximal femur were generated to estimate femoral strength using FE analysis and to derive structural bone parameters. Over a mean follow-up of 5.7 ± 1.5 years, 100 low-trauma fractures were recorded, including 44 major osteoporotic fractures (MOF), 89% at non-hip sites. Femoral strength, total and trabecular vBMD, some cortical parameters, and conventional areal BMD were all significantly associated with incident low-trauma fractures (risk increase of 23-38% per SD decrease) and major osteoporotic fractures (36-59%), with femoral strength showing hazard ratios (95% confidence interval) of 1.32 (1.08-1.60) and 1.50 (1.12-2.01), respectively. A strength threshold of 2600 N improved fracture risk classification beyond conventional aBMD thresholds and outperformed the previously proposed fragile strength 3000 N threshold. Notably, 25% of women with low-trauma fractures and 27% with MOF were non-osteoporotic by aBMD but exhibited fragile femoral strength (≤3000 N), with 14% and 16% respectively below the very fragile threshold (≤2600 N). In conclusion, 3D DXA-derived femoral strength provides complementary value to aBMD in identifying women at elevated fracture risk, particularly those not classified as osteoporotic by conventional criteria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.